lobbying_activities: 2034960
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2034960 | 4b328bc9-d87d-4d99-b62c-c838a1d57c2d | Q3 | ERVIN GRAVES STRATEGY GROUP, LLC | 13836 | EMERGENT BIOSOLUTIONS INC. | 2017 | third_quarter | DIS | FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense | Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-10-19T14:23:28.437000-04:00 |